Journal of Medical Case Reports
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
Case reportMesothelioma of the testis and nephrotic syndrome: a case reportJustine Bacchetta1 , Dominique Ranchère1 , Frédérique Dijoud2 and Jean-Pierre Droz1  1
Departments of Medical Oncology and Pathology, Centre Léon Bérard, Lyon and Université Claude Bernard Lyon 1, France 2
Department of Pathology, Hôpital Femme Mère Enfant, Bron and Université Claude Bernard Lyon 1, France author email corresponding author email
Journal of Medical Case Reports 2009,
3:7248doi:10.1186/1752-1947-3-7248 Abstract
Introduction
Paraneoplastic glomerulopathies are rare manifestations of neoplastic disease to be distinguished from iatrogenic renal damage. Solid tumors are preferentially associated with membranous nephropathy, whereas Hodgkin's lymphomas are associated with minimal change disease.
Case presentation
We report a 63-year-old Caucasian male diagnosed with a mesothelioma of the tunica vaginalis testis who, secondary to this, also presented with a nephrotic syndrome due to minimal change disease. In the present case, the paraneoplastic etiology of the nephrotic syndrome can be discussed on four unusual elements: minimal change lesions were found; the glomerulopathy was very sensitive to corticosteroids; the nephrotic syndrome occurred 11 months after the diagnosis of the primary malignancy, but concomitantly with the recurrence; and the nephrotic syndrome did not decrease with tumor control and did not recur when the mesothelioma escaped treatment. No other etiologies could nevertheless explain this phenomenon.
Conclusion
Paraneoplastic nephrotic syndrome is often associated with membranous nephropathy in patients with solid tumors, especially in patients with lung and gastrointestinal tract neoplasia. The management of these patients is associated with a symptomatic treatment such as sodium and water restriction, diuretics and ACE inhibitors and a prophylaxis of specific complications of nephrotic syndrome including thromboembolism, infections and lipid abnormalities. Treatment of neoplasia must be undertaken rapidly, treatments must be regularly analyzed and drugs binding to albumin may be used with precaution. |